Objective To identify the optimal dose and type of physical activity to improve functional capacity and reduce adverse events in acutely hospitalised older adults. Design Systematic review and ...

Adverse effects associated with glucocorticoid use among patients with rheumatoid arthritis may not be as burdensome as previously indicated. Glucocorticoids are one of the most common methods for ...

Serplulimab achieves pharmacodynamic saturation, supporting its current clinical use without the need for higher doses. The ASTRUM-005 trial established serplulimab as the PD-1 inhibitor with the ...

Retatrutide (LY3437943) is an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors. Its dose–response relationships with respect to side effects ...